Abstract
This retrospective study describes the clinical profile, risk of infection and outcome of coronavirus disease-19 in immunocompromised children. It was found that children on immunosuppressant medication has 2.89 times increased risk of infection (P=0.01). Disease manifestation was asymptomatic (P=0.01) or mild with predominant gastrointestinal symptoms (P=0.02) without alteration in immunosuppressive treatment regime.
Article PDF
References
Meena J, Yadav J, Saini L, et al. Clinical features and outcome of SARS-CoV-2 infection in children: A systematic review and metaanalysis. Indian Pediatr. 2020;57:820–26.
Marlais M, Wlodkowski T, Vivarelli M, et al. The severity of COVID-19 in children on immunosuppressive medication. Lancet Child Adolesc Health. 2020;4:e17–18.
Marlais M, Wlodkowski T, Al-Akash S, et al. COVID-19 in children treated with immunosuppressive medication for kidney disease. Arch Dis Child. 2020 Dec 21;archdischild-2020-320616 (Online ahead of print).
El Dannan H, Al Hassani M, Ramsi M. Clinical course of COVID-19 among immunocompromised children: A clinical case series BMJ. Case Rep. 2020;13:e237804.
Minotti C, Tirelli F, Barbieri E, et al. How is immunosuppressive status affecting children and adults in SARS-CoV-2 infection? A systematic review. J Infection. 2020;81: e61–66.
Vasudevan A, Mantan M, Krishnamurthy S, et al. Managing children with renal diseases during the COVID-19 pandemic. Indian Pediatr. 2020;57:641–51.
Government of India, Ministry of Health and Family Welfare Guidelines on clinical management of COVID-19. Directorate General of Health Services (EMR Division); p. 3–5. Accessed December 23, 2020. Available from: https://www.mohfw.gov.in/pdf/Guidelines on Clinical Management of COVID 1912020.pdf
Hrusak O, Kalina T, Wolf J, et al. Flash survey on severe acute respiratory syndrome coronavirus-2 infections in paediatric patients on anticancer treatment. Euro J Cancer. 2020;132:11–16.
Alvarado A, Franceschi G, Resplandor E, et al. COVID-19 associated with onset nephrotic syndrome in a pediatric patient: Coincidence or related conditions?. Pediatr Nephrol. 2021;36:205–07.
Harambat J, Allard L, Godron-Dubrasquet A. Relapse rate of nephrotic syndrome in the time of COVID-19. Pediatr Nephrol. 2021;36:211–12.
Author information
Authors and Affiliations
Corresponding author
Additional information
Contributors
SKR, RP, VG, OPM: concept, design, drafting of the manuscript, critical analysis; AK: acquisition of data, analysis and interpretation. All authors approved the final version of manuscript, and are accountable for all aspects related to the study.
Funding
None
Competing interests
None stated.
Rights and permissions
About this article
Cite this article
Rao, S.K., Kumar, A., Prasad, R. et al. Clinical Profile and Outcome of COVID-19 Among Immunocompromised Children. Indian Pediatr 58, 686–687 (2021). https://doi.org/10.1007/s13312-021-2267-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13312-021-2267-6